Onconova Uses Rave to Improve Patient Screening

Onconova Therapeutics relied on manual patient-screening via emails and untracked phone calls, risking loss of qualified candidates for rare-cancer-indication trials. It implemented Medidata's Rave platform along with Rave Coder+, RTSM, and TSDV modules to build an electronic screening system with audit trails and automated notifications. The page states this delivered improved data quality through ongoing consolidated review, reduced monitoring costs via risk-based approaches, and a flexible study-build model balancing outsourcing with in-house configuration based on resource availability.

Medidata is a Dassault Systèmes company supplying the clinical-trial EDC and data platform (Rave) most sponsors and CROs already run live trials on, now with an AI layer built in.

This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.